- MS-DRGs are grouped by "Medical Service" to provide a meaningful way of summarizing utilization data.
- MS-DRGs are based on FY 2021 regulations.
| MS-DRG | MS-DRG Description |
|---|---|
| 014 | ALLOGENEIC BONE MARROW TRANSPLANT |
| 016 | AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC |
| 017 | AUTOLOGOUS BONE MARROW TRANSPLANT WITHOUT CC/MCC |
| 018 | CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY |
| 054 | NERVOUS SYSTEM NEOPLASMS WITH MCC |
| 055 | NERVOUS SYSTEM NEOPLASMS WITHOUT MCC |
| 146 | EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC |
| 147 | EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC |
| 148 | EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC |
| 180 | RESPIRATORY NEOPLASMS WITH MCC |
| 181 | RESPIRATORY NEOPLASMS WITH CC |
| 182 | RESPIRATORY NEOPLASMS WITHOUT CC/MCC |
| 374 | DIGESTIVE MALIGNANCY WITH MCC |
| 375 | DIGESTIVE MALIGNANCY WITH CC |
| 376 | DIGESTIVE MALIGNANCY WITHOUT CC/MCC |
| 435 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC |
| 436 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC |
| 437 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC |
| 597 | MALIGNANT BREAST DISORDERS WITH MCC |
| 598 | MALIGNANT BREAST DISORDERS WITH CC |
| 599 | MALIGNANT BREAST DISORDERS WITHOUT CC/MCC |
| 686 | KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC |
| 687 | KIDNEY AND URINARY TRACT NEOPLASMS WITH CC |
| 688 | KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC |
| 722 | MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC |
| 723 | MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC |
| 724 | MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC |
| 754 | MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC |
| 755 | MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC |
| 756 | MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC |
| 834 | ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC |
| 835 | ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC |
| 836 | ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC |
| 837 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC |
| 838 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT |
| 839 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC |
| 840 | LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC |
| 841 | LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC |
| 842 | LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC |
| 843 | OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC |
| 844 | OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC |
| 845 | OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC |
| 846 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC |
| 847 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC |
| 848 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC |
| 849 | RADIOTHERAPY |